ArticleAmerican journal of translational research2026
Immunotherapy-combined chemotherapy as first-line treatment for stage IIIB/IV large cell neuroendocrine lung carcinoma.
Zhuoran Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.